Efficacy and safety of posteroventral pallidotomy for the treatment of advanced Parkinson disease;Efectividad y seguridad de la palidotomía posteroventral en el tratamiento de la enfermedad de Parkinson avanzada

Medicina Clinica

Volumn 114, Issue 6, 2000, Pages 205-208

  Molinuevo, José Luis ^a   Valldeoriola, Francesc ^a   Rumiá, Jordi ^a   Nobbe, Fritz A ^a   Ferrer, Enric ^a   Tolosa, Eduardo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Dyskinesias; Parkinson's disease pallidotomy

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

AGED; ARTICLE; DYSKINESIA; FEMALE; GLOBUS PALLIDUS; HUMAN; MALE; MIDDLE AGED; PARKINSON DISEASE; STEREOTAXIC SURGERY; TREATMENT OUTCOME;

AGED; ANTIPARKINSON AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; GLOBUS PALLIDUS; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME;

EID: 0042223854     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(00)71245-0     Document Type: Article

References (38)

1. Narabayashi H, Okuma T. Procaine-oil blocking of the globus pallidus for the treatment of rigidity and tremor of parkinsonism. Proc Jpn Acad 1953; 29: 134-137.
2. Guiot G, Brion S. Traitement des mouvements anormaux par la coagulation pallidale: Technique et résultats. Rev Neurol 1953; 89: 578-580.
3. Hassler R, Riechert T. Indikationen und Lokalisations-methode der gezielten Hirnoperationen. Nervenarzt 1954; 25: 441-447.
4. Cooper IS, Bravo G. Chemopallidectomy and chemothalamectomy. J Neurosurg 1958; 15: 244-250.
5. Peiro Grasa A, Grau-Veciana JM. Efectos secundarios de la levodopaterapia prolongada en la enfermedad de Parkinson. Med Clin (Barc) 1985; 85: 88-91.
6. Molina Arjona JA, Arnal Gracia C. Calandre Hoenigsfeld L, Bermejo Pareja F. Distonia de la mañana temprana: una complicación de la terapéutica con levodopa en la enfermedad de Parkinson. Presentación de 6 casos. Med Clin (Barc) 1984, 83: 47-49.
7. Svennilison A, Torvik A, Lowe R, Leksell L. Treatment of parkinsonism by sterotactic chernolesions in the pallidal region. Acta Psychiatr Scand 1960; 35: 358-377.
8. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992; 76: 52 61.
9. Baron MS, Vitek JL, Bakay RAE, Grenn J, Kaneoke Y, Hashimoto T et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996; 40: 355-366.
10. Lozano AM, Lang AE, Gálvez-Jiménez N, Miyasaki J, Duff J, Hutchinson W et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995; 346: 1383-1387.
11. Dogali M, Fazzini E, Kolodny E, Eidelberg D, Sterio D, Devinsky O et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995; 45: 753-761.
12. Shannon KM, Penn RD, Kroin JS, Adler CH. Janko KA, York M et al. Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy arid adverse effects at 6 months in 26 patients. Neurology 1998; 50: 434-438.
13. Fazzini E, Dogali M, Sterio D, Eidelberg D. Beriç A. Stereotactic pallidotomy for Parkinson's disease. A long-term follow-up of unilateral pallidotomy. Neurology 1997; 48: 1273-1277.
14. Sutton JP, Couldwell W, Lew MF, Mallory L, Grafton S, DeGiorgio C et al. Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease. Neurosurgery 1995; 36: 1112-1117.
15. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
16. Fahn S, Elton RL, members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. En: Fahn S, Marsden CD, Calne DB, Golgstein M, editores. Recent developments in Parkinson's Disease. Vol 2. Florham Park, NJ: MacMillan Health Care Information, 1987; 153-164.
17. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992; 7: 2-13.
18. Sweet RA, DeSensi EG, Zubenko GS, Reliability and applicability of movement disorder rating scales in the elderly. J Neuropsychiatry Clin Neurosci 1993; 5: 56-60.
19. Schwab RS, England RC. Projection technique for evaluating surgery in Parkinson's disease. En: Gillingham FJ, Donaldson IML, editores. Third Symposium on Parkinson's disease. Edimburgo: E y S Livingstone, 1969; 152-157.
20. Nobbe FA, Valldeoriola F, Tolosa E, Rumia J. Ferrer E, Fábregas N. Self-assessment scales show functional improvement and reduction of motor fluctuations after electrophysiological guided pallidotomy in Parkinson's disease. J Neurol 1997; 244: 121.
21. Brown RG, Phil M, MacCarthy B, Jahanshahi M, Marsden CD. Accuracy of self reported disability in patients with parkinsonism. Arch Neurol 1989; 46: 955-959.
22. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
23. Martinez-Martin P, Valldeonola F, Molinuevo JL, Nobbe FA. Tolosa E. Pallidotomy and quality of life in Parkinson's disease. An early study with the PDQ-39. Mov Disord (en prensa).
24. Schaltenbrand G, Wahren W. Atlas for stereotaxy of the human brain. Stuttgart: Thieme, 1977.
25. Lozano A, Hutchinson W, Kiss Z, Tasker R, Davis K, Dostrovsky J. Methods for microelectrode guided posteroventral pallidotomy. J Neurosurg 1996; 84: 294-202.
26. Parent A, Hazrati LN. Functional anatomy of the basal ganglia I. The cortico-basalthalamo-cortical loop. Brain Res Rev 1995; 91-127.
27. Baron MS, Vitek JL, Bakay RAE, DeLong MR. Treatment of advanced Parkinson's disease by unilateral posterior GPi pallidotomy: 4-years result of a pilot study. Mov Disord 1998; 13 (Supl 2). 263.
28. Marsden DC, Obeso J. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994; 117: 877-897.
29. Alexander GE, De Long MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Anni Rev Neurosci 1986; 9: 357-381.
30. Alexander GE, Crutcher MD. Functional architecture of the basal ganglia circuitry: neural substrates of parallel processing. Trends Neurosci 1990; 13: 266-271.
31. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990; 13: 281-285.
32. Grafton ST, Waters C, Sutton J, Lew MF, Couldwell W. Pallidotomy increases activity of motor association cortex in Parkinson's disease: a positron emission tomographic study. Ann Neurol 1995; 37: 776-783.
33. Eidelberg D, Moellers JR, Ishikawa T, Dhawan V, Spetsieris P, Silbersweig D et al. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Ann Neurol 1996; 39: 450-459.
34. Ceballos-Baumann AO, Obeso JA, Vitek JL, DeLong MR, Bakay R, Linazasoro G et al. Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease. Lancet 1994; 344: 814.
35. Linazasoro G, Gorospe A, Rodriguez MC, Guridi J, Ramos E, Mozo A et al. Palidotomia en el tratamiento de la enfermedad de Parkinson complicada: resultados clinicos a los dos años y análisis de factores pronósticos. Neurología 1999; 14: 53-61.
36. Limousin P, Krack P, Pollack P, Benazzouz A, Ardouin C, Hoffman D et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998; 339: 1105-1111.
37. Krack P, Pollan P, Limousin P, Hoffmann D, Xie J, Benazzouz P et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998; 121: 451-457.
38. Kumar R, Lozano AM, Kim YJ, Hutchinson WD, Sime E, Halket et al. Doubleblind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998; 51: 850-855.